2010
//
Network Medicine

Blueprint for antimicrobial hit discovery targeting metabolic networks

Abstract
Proceedings of the National Academy of Sciences of the United States of America 10.1073, 1-6 (2010) Advances in genome analysis, network biology, and computational chemistry have the potential to revolutionize drug discovery by combining system-level identification of drug targets with the atomistic modeling of small molecules capable of modulating their activity. To demonstrate the effectiveness of such a discovery pipeline, we deduced common antibiotic targets in Escherichia coli and Staphylococcus aureus by identifying shared tissue-specific or uniformly essential metabolic reactions in their metabolic networks. We then predicted through virtual screening dozens of potential inhibitors for several enzymes of these reactions and showed experimentally that a subset of these inhibited both enzyme activities in vitro and bacterial cell viability. This blueprint is applicable for any sequenced organism with high-quality metabolic reconstruction and suggests a general strategy for strain-specific antiinfective therapy.

..

More publications
H. Yu, P. Braun, M. A. Yildirim, I. Lemmens, K. Venkatesan, J. Sahalie, T. Hirozane-Kishikawa, F. Gebreab, N. Li, N. Simonis, T. Hao, J.-F. Raul, A. Dricot, A. Vazquez, R. R. Murray, C. Simon, L. Tardivo, S. Tam, N. Svrzikapa, C. Fan, A.-S. de Semt, A. Motyl, M. E. Hudson, J. Park, X. Xin, M. E. Cusick, T. Moore, C. Boone, M. Snyder, F. P. Roth, A.-L. Barabási, J. Tavernier, D. E. Hill, M. Vidal

Science 322, 104-110 (2008)

view
J. Lim, T. Hao, C. Shaw, A.J. Patel, G. Szabo, J.F. Rual, C.J. Fisk, N. Li, A. Smolyar, D.E. Hill, A.-L. Barabási, M. Vidal, H.Y. Zoghbi

Cell 125, 801-814 (2006)

view
A. Vazquez, Q. K. Beg, M. A. de Menezes, J. Ernst, Z. Bar-Joseph, A.-L. Barabási, L. G. Boros, Z. N. Oltvai

BMC Systems Biology 2:7, 1-10 (2008)

view